Coral Laboratories board meets Sep 25 to approve FY26 cost audit

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Board meeting scheduled for September 25, 2026
  • Agenda includes approval of FY26 cost audit report
  • Intimation issued under SEBI LODR Regulation 29
  • Signed by Director and CFO Sushma Kadkade
powered bylight_fuzz_icon
51516871

*this image is generated using AI for illustrative purposes only.

Coral Laboratories will hold a board meeting on Friday, September 25, 2026, to approve its cost audit report for the financial year 2025-26.

The company notified the BSE Limited regarding the meeting pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Agenda

The Board of Directors is scheduled to consider and approve the following items:

  • Cost Audit report for the financial year 2025-26
  • Any other business with the permission of the chairman

Sushma Kadkade, Director and CFO, signed the intimation on September 21, 2026.

Historical Stock Returns for Coral Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.71%-3.25%-10.66%+32.48%+5.80%0.0%

How might the findings in the FY 2025-26 cost audit report influence Coral Laboratories' pricing strategies and margin projections for the upcoming fiscal year?

Are there any anticipated regulatory implications or compliance adjustments for Coral Laboratories following the approval of this cost audit?

Could the cost audit results signal any operational inefficiencies that the board plans to address through strategic restructuring or technology investments?

Coral Laboratories proposes ₹2 per share dividend for FY26

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Coral Laboratories proposes a final dividend of ₹2.00 per share for FY26
  • The 44th AGM is scheduled for September 29, 2026, via video conferencing
  • FY26 income fell to ₹9,579.68 lakh from ₹12,411.39 lakh in FY25
  • Net profit declined to ₹1,683.13 lakh compared to ₹2,415.56 lakh previously
powered bylight_fuzz_icon
49965528

*this image is generated using AI for illustrative purposes only.

Coral Laboratories has scheduled its 44th Annual General Meeting for September 29, 2026. The company intends to propose a final dividend of ₹2.00 per equity share for the financial year ending March 31, 2026.

The meeting will be conducted through video conferencing or other audio-visual means in compliance with Ministry of Corporate Affairs circulars. Shareholders can participate remotely to transact the business set out in the notice.

Dividend and Book Closure Details

The Register of Members and transfer books will remain closed from September 23, 2026, to September 29, 2026. This closure is to ascertain the list of members entitled to receive the proposed dividend.

Detail Information
Proposed Dividend ₹2.00 (20%) per share
Face Value ₹10
Financial Year FY26
Book Closure Start September 23, 2026
Book Closure End September 29, 2026
Record Date September 22, 2026

Eligibility is determined by names appearing in the beneficial owner list furnished by depositories or the register of members as of the end of business hours on Tuesday, September 22, 2026.

Payment and Tax Implications

Dividend payments will be made electronically after September 30, 2026. The company mandates using bank account details furnished by depositories or maintained by the Registrar and Transfer Agent. Tax at source will be deducted as per the Finance Act, 2025. Members are requested to submit necessary documents by September 18, 2026, to determine the appropriate tax rate.

Financial Performance

For FY26, Coral Laboratories reported income of ₹9,579.68 lakh, down from ₹12,411.39 lakh in FY25. Earnings after tax stood at ₹1,683.13 lakh, compared to ₹2,415.56 lakh in the previous year. Exports decreased to ₹7,707.14 lakh from ₹9,382.14 lakh.

What the Numbers Show

The proposed dividend payout represents a 20% yield on the ₹10 face value of the equity shares. This indicates a consistent return mechanism for shareholders holding physical or demat shares as of the record date, despite the decline in operational revenue and profit.

Historical Stock Returns for Coral Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.71%-3.25%-10.66%+32.48%+5.80%0.0%

How will Coral Laboratories' management address the 22% decline in FY26 revenue and profit margins in their upcoming strategic roadmap?

What specific operational or market factors contributed to the significant drop in export earnings from ₹93.8 crore to ₹77.0 crore in FY26?

Given the reduced profitability, is the proposed ₹2.00 dividend sustainable for future fiscal years, or does it signal a shift in capital allocation strategy?

More News on Coral Laboratories

1 Year Returns:+5.80%